康美键胶囊联合放化疗治疗癌症的临床观察.docxVIP

康美键胶囊联合放化疗治疗癌症的临床观察快特新生物工程研究所 陈松伟摘要动物实验证明：康美键胶囊（甲壳多糖）对人体免疫系统作用效果显著[1]。自1996年1月～1999年1月通过各临床医院合作选择73例癌症病人，按治疗组：康美键胶囊（甲壳多糖）联合放化疗38例;对照组：单纯性放化疗35例，观察其临床疗效，结果证明：康美键胶囊（甲壳多糖）联合放化疗的临床效果优于单纯放化疗。表明康美键胶囊（甲壳多糖）在抗癌治疗中具有协调作用，提高人体免疫功能，减轻放化疗过程的副作用，提高病人的生活质量，有利于癌症病人的综合生物治疗。关键词 康美键胶囊（甲壳多糖）联合治疗?癌症CLINICAL OBSERVATIDNS ON CURING CANCERS BY COMBINED??APPLICATION OF CHITOTIN CAPSULE.Chen Sonwei. The Chitosan Biochemistry??Engincering Institute ChaoZhou，521000Abstrant Observe the functions of chitotin capsule（cuitin＆chitosan） in increasing the immunity against tum0urs and eliminating harmful?? substances from the body.Of the 73 cancer patients accepted from January of 1996 to??January of l999,38 cases in the cure group received combined radioactive?? treatment with chitotin capsule(chitin chitosan). 35 cases in the control?? group received traditional radioactive treatment,recent cure effects are??observed for comparison.The rates of effectiveness in the treatment of the cure?? group aud the control group are 80.56% and 55.40% respectively. The rates of?? normal stability of the subpopulation of T-lymphocyte of the blood are 83.33%?? and 51.11% respectively； The rates of normal functioning of the liver and the?? kidney are 97.37% and 92.62% respectively; The rates of discontinuation of?? radioactive treatment are 7.89% and 31.43% respectively.The recent curing effect of radioactine treat ment with?? combined applieation of chitotin capsule （chitin＆chitosan）is more significant?? than that from traditional radioactive treatment.Key words Chitotin capsule（chitin＆chitosan）Combinedtreatment． Cancer.国外文献报道：几丁质具有抗癌、抑制癌细胞转移，提高人体免疫功能的作用[2]。自1996年1月至1999年1月通过与临床医院合作选择73例癌症病人，尤其进行放化疗过程中，给予康美键胶囊（甲壳多糖），观察其临床治疗效果，具体报告如下：对 象 与 方法一、对象：癌症病人73例，男性患者45例，女性患者28例，男女比例约为1．6：l。年龄45～49岁6例，占8．22%；50～54岁36例，占49．31%；55～59岁26例，占35．62%；60～64岁5例，占6．85%。73例癌症患者中，恶性淋巴瘤7例，肺癌6例，食道癌12例，原发性肝癌3例，脑转移癌7例，肝转移癌6例，骨癌5例，直肠癌9例，乳腺癌8例。治疗组：康美键胶囊（甲壳多糖）加放化疗38例（放疗14例，化疗8例，放化疗16例），对照组：单纯性放化疗35例（放疗12例、化疗8例、放化疗15例）。二、临床方法：73例癌症患者全部经临床、病理、